Overview

Comparison Of Two Tablet Formulations Of SB-568859

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
SB-568859 is a medication that is being developed for the treatment of atherosclerosis (hardening of the arteries). The purpose of this study is to see if there is a difference in how the human body takes up the study drug depending on how the study drug is made. This study will compare SB-568859 tablets that are made in 2 different ways. This is not a treatment study.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline